ArticleOncotarget2018

Lenalidomide combined with low-dose cyclophosphamide and prednisone modulates Ikaros and Aiolos in lymphocytes, resulting in immunostimulatory effects in lenalidomide-refractory multiple myeloma patients.

Laurens E Franssen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.